SNDL achieves EU-GMP certification at New Brunswick cannabis facility

Sundial Growers passes European Good Manufacturing Practice audit, potentially expanding medical export pathways for Canadian producer.

FILE — statehouse · B.D. Gilfry / CC BY-SA 2.0

Sundial Growers (SNDL) has secured EU-GMP certification at its New Brunswick facility, according to Cannabis Business Times. The audit represents a regulatory milestone for the Canadian producer, signaling compliance with European pharmaceutical manufacturing standards that typically gate access to medical cannabis markets in the EU and other jurisdictions requiring comparable quality assurance.

The certification arrives as Canadian medical cannabis faces renewed trade scrutiny—Israel reopened an anti-dumping investigation into Canadian medical imports this week—and amid broader questions about domestic supply chain consolidation. Recent acquisitions by Red White & Bloom and Canopy Growth suggest competition remains intense for manufacturing capacity and export licensing.

The immediate question is whether SNDL will use the EU-GMP status to accelerate medical exports or to shore up domestic licensing for already-saturated Canadian markets. Watch for announcements of specific EU distribution agreements or regulatory filings in the coming weeks.